Resveratrol in human hepatoma HepG2 cells: Metabolism and inducibility of detoxifying enzymes

Drug Metabolism and Disposition

Volumn 35, Issue 5, 2007, Pages 699-703

  Lançon, Allan ^a,b   Hanet, Nathalie ^b   Jannin, Brigitte ^a,b   Delmas, Dominique ^a,b   Heydel, Jean Marie ^b   Lizard, Gerard ^a,b   Chagnon, Marie Christine ^b   Artur, Yves ^b   Latruffe, Norbert ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 2B7; RESVERATROL; RESVERATROL DISULFATE; RESVERATROL MONOSULFATE; SULFOTRANSFERASE; UNCLASSIFIED DRUG; VERLUKAST;

ARTICLE; CANCER CELL CULTURE; CHEMOPROPHYLAXIS; CYTOMETRY; DETOXIFICATION; DRUG ACTIVITY; DRUG IDENTIFICATION; DRUG METABOLISM; DRUG STRUCTURE; HEPATOMA CELL; HUMAN; HUMAN CELL; IC 50; MASS SPECTROMETRY; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME INDUCTION; ENZYMES; FLOW CYTOMETRY; GLUCURONOSYLTRANSFERASE; HUMANS; LIVER NEOPLASMS; MASS SPECTROMETRY; METABOLIC DETOXICATION, PHASE II; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PROPIONATES; QUINOLINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STILBENES; SULFOTRANSFERASES; TIME FACTORS; TRITIUM;

EID: 34247399158     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.106.013664     Document Type: Article

References (22)

1. Adrian M, Jeandet P, Douillet-Breuil AC, Tesson L, and Bessis R (2000) Stilbene content of mature Vitis vinifera berries in response to UV-C elicitation. J Agric Food Chem 48:6103-6105.
2. Aumont V, Krisa S, Battaglia E, Netter P, Richard T, Merillon JM, Magdalou J, and Sabolovic N (2001) Regioselective and stereospecific glucuronidation of trans- and cis-resveratrol in human. Arch Biochem Biophys 393:281-289.
3. Congiu M, Mashford ML, Slavin JL, and Desmond PV (2002) UDP glucuronosyltransferase mRNA levels in human liver disease. Drug Metab Dispos 30:129-134.
4. Delmas D, Jannin B, and Latruffe N (2005) Resveratrol preventing properties against vascular alterations and ageing. Mol Nutr Food Res 49:377-395.
5. Delmas D, Lancon A, Colin D, Jannin B, and Latruffe N (2006) Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer. Curr Drug Target 7:423-442.
6. Delmas D, Rebe C, Lacour S, Filomenko R, Athias A, Gambert P, Cherkaoui-Malki M, Jannin B, Dubrez-Daloz L, Latruffe N, et al. (2003) Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death inducing signaling complex in colon cancer cells. J Biol Chem 278:41482-41490.
7. Delmas D, Rebe C, Micheau O, Athias A, Gambert P, Grazide S, Laurent G, Latruffe N, and Solary E (2004) Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells. Oncogene 23:8979-8986.
8. De Santi C, Pietrabissa A, Mosca F, and Pacifici GM (2000a) Glucuronidation of resveratrol, a natural product present in grapes and wine, in the human liver. Xenobiotica 30:1047-1054.
9. De Santi C, Pietrabissa A, Spisni R, Mosca F, and Pacifici GM (2000b) Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum. Xenobiotica 30:609-617.
10. Hebbar V, Shen G, Hu R, Kim BR, Chen C, Korytko PJ, Crowell JA, Levine BS, and Kong AN (2005) Toxicogenomics of resveratrol in rat liver. Life Sci 76:2299-2314.
11. Henry C, Vitrac X, Decendit A, Ennamany R, Krisa S, and Merillon JM (2005) Cellular uptake and efflux of trans-piceid and its aglycone trans-resveratrol on the apical membrane of human intestinal Caco-2 cells. J Agric Food Chem 53:798-803.
12. Kaldas MI, Walle UK, and Walle T (2003) Resveratrol transport and metabolism by human intestinal Caco-2 cells. J Pharm Pharmacol 55:307-312.
13. Lançon A, Delmas D, Osman H, Thénot JP, Jannin B, and Latruffe N (2004) Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process. Biochem Biophys Res Commun 316:1132-1137.
14. Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, and Ducharme MP (2002) Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 302:369-373.
15. Miksits M, Maier-Salamo A, Aust S, Thalhammer T, Teznicek G, Kunert O, Haslinger E, Szeleres T, and Jaeger X (2005) Sulfation of resveratrol in human liver: evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1. Xenobiotica 35:1101-1119.
16. Pfaffl MW, Horgan GW, and Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:e36.
17. Sergent T, Garsou S, Schaut A, De Saeger S, Pussemier L, Van Peteghem C, Larondelle Y, and Schneider YJ (2005) Differential modulation of ochratoxin A absorption across Caco-2 cells by dietary polyphenols, used at realistic intestinal concentrations. Toxicol Lett 159:60-70.
18. Vitaglione P, Sforza S, Galaverna G, Ghidini C, Caporaso N, Vescovi PP, Fogliano V, and Marchelli R (2005) Bioavailability of trans-resveratrol from red wine in humans. Mol Nutr Food Res 49:495-504.
19. Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, and Walle UK (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32:1377-1382.
20. Wenzel E and Somoza V (2005) Metabolism and bioavailability of trans-resveratrol. Mol Nutr Food Res 49:472-481.
21. Wenzel E, Soldo T, Erbersdobler H, and Somoza V (2005) Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Mol Nutr Food Res 49:482-494.
22. Zhu Z, Klironomos G, Vachereau A, Neirinck L, and Goodman DW (1999) Determination of trans-resveratrol in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 724:389-392.